Lineage Cell Therapeutics, Inc.
LCTX
$0.4817
-$0.0183-3.66%
LCTX market cap represents
0.00%
of the sector.
Valuation
LCTX
Low
LCTX
Sector Average
High
Market Cap
114.18M
< 114.18M
> 16.18B
Enterprise Value
67.52M
< 60.00M
> 18.28B
Price/Earnings (TTM)
-5.21
< -10.00
> 10.00
Earnings Per Share Growth (TTM)
-22.83%
< -50.00%
> -10.00%
Price/Earnings To Growth (TTM)
--
0.00
12.73
Price/Sales (TTM)
12.66
< 10.000
> 440.00
Price/Book (Q)
1.41
< 0.00
> 20.00
Enterprise Value/Revenue (TTM)
7.11
< 0.00
> 210.00
Enterprise Value/EBITDA (TTM)
-3.24
< -10.00
> 0.00
Enterprise Value/EBIT (TTM)
-3.14
< -10.00
> 10.00
Dividends and Shares
LCTX
Low
LCTX
Sector Average
High
Shares Outstanding
240.19M
< 50.00M
> 250.00M
Dividend Per Share (Most Recent)
--
0.00
2.38
Dividend Per Share (TTM)
--
0.00
9.13
Dividend Yield (TTM)
--
0.00%
7.73%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
LCTX
Low
LCTX
Sector Average
High
Beta
0.94
< 0.00
4.52
1-Month Total Return
-31.02%
< -40.00%
> 0.00%
3-Month Total Return
-0.30%
< -10.00%
> 0.00%
6-Month Total Return
-43.18%
< -50.00%
> 10.00%
Year to Date Total Return
-2.91%
< -20.00%
> 0.00%
1-Year Total Return
-57.26%
< -60.00%
> 20.00%
2-Year Total Return
-63.77%
< -70.00%
> 50.00%
3-Year Total Return
-64.54%
< -70.00%
> 0.00%
5-Year Total Return
-16.68%
< -20.00%
> 240.00%
Profitability
LCTX
Low
LCTX
Sector Average
High
Operating Margin (TTM)
-226.10%
< -12,920.00%
> -220.00%
Profit Margin (TTM)
-195.90%
< -12,650.00%
> -190.00%
Management Effectiveness
LCTX
Low
LCTX
Sector Average
High
Return on Assets (TTM)
-12.53%
< -60.00%
> -10.00%
Return on Equity (TTM)
--
0.26%
824.40%
Income Statement
LCTX
Low
LCTX
Sector Average
High
Revenue (TTM)
9.50M
< 0.00
> 12.14B
Total Revenue (TTM)
9.50M
< 0.00
> 12.33B
Total Revenue Growth (Q YOY)
37.36%
< 30.00%
> 2,380.00%
Revenue Per Share (TTM)
0.04
< 0.00
> 180.00
Gross Profit (TTM)
-3.31M
< -10.00M
> 3.69B
EBITDA (TTM)
-20.87M
< -30.00M
> 1.07B
EBIT (TTM)
-21.48M
< -30.00M
> 710.00M
Net Income (TTM)
-18.61M
< -20.00M
> 270.00M
Net Income Avl. to Common (TTM)
-18.61M
< -20.00M
> 270.00M
Earnings Growth (Q YOY)
31.06%
< -300.00%
> 40.00%
EPS Diluted (TTM)
-0.10
< -5,360.00
> 0.00
EPS Diluted Growth (Q YOY)
50.18%
< -20.00%
> 60.00%
Balance Sheet
LCTX
Low
LCTX
Sector Average
High
Cash and Short-Term Inv. (Q)
47.81M
< 40.00M
> 1.35B
Cash Per Share (Q)
0.20
0.00
> 200.00
Total Current Assets (Q)
51.00M
< 50.00M
> 3.40B
Total Assets (Q)
113.22M
< 110.00M
> 9.63B
Total Current Liabilities (Q)
13.98M
< 10.00M
> 2.53B
Total Debt (Q)
2.51M
0.00
> 3.10B
Total Liabilities (Q)
36.21M
< 30.00M
> 6.05B
Total Common Equity (Q)
78.38M
< 70.00M
> 3.49B
Total Preferred Equity (Q)
--
0.00
383.90M
Total Equity (Q)
77.01M
< 70.00M
> 3.59B
Current Ratio (Q)
3.649
0.009
> 20.000
Book Value Per Share (Q)
0.36
< 0.00
> 2,130.00
Cash Flow
LCTX
Low
LCTX
Sector Average
High
Cash from Operations (TTM)
-23.09M
< -30.00M
> 710.00M
Cash from Investing (TTM)
-2.31M
< -570.00M
> 0.00
Cash from Financing (TTM)
35.86M
< -180.00M
> 40.00M
Net Change in Cash (TTM)
10.36M
< -30.00M
> 20.00M
Levered Free Cash Flow (TTM)
-12.80M
< -20.00M
> 530.00M
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the sector.
